Feb 10, 2023

January 25, 2025

This week’s newsletter included:

• BioUtah on Capitol Hill

• FDA 510(k) Clearance, CLIA-Waiver for Innovative BioFire® SpotFire® System and Respiratory Panel

• Renalytix Announces a c.$20.3 Million Private Placement

• Sumitomo Pharma Oncology Presented Preliminary Data From Phase 1 & 2 Clinical Study in Patients With Myelofibrosis at American Society of Hematology 2022 Annual Meeting

• HOSA Judging Opportunity

• 100 Companies Championing Women Nomination Application

Featured New Member: Teva Pharmaceuticals